SOX2 and adenocarcinoma: Lastly, we demonstrated that SOX2 protein expression was largely significantly elevated in lung SCCs relative to adenocarcinomas following analyses of two independent TMA sets and copy gain of the gene was evident in 20% of lung SCCs studied and absent in adenocarcinomas.